| Pyrotinib treatment in patients with HER2-positive metastatic breast cancer and brain metastasis: exploratory final analysis of real-world, multicenter data M Anwar, Q Chen, D Ouyang, S Wang, N Xie, Q Ouyang, P Fan, L Qian, ... Clinical Cancer Research 27 (16), 4634-4641, 2021 | 43 | 2021 |
| Effectiveness and safety of pyrotinib, and association of biomarker with progression-free survival in patients with HER2-positive metastatic breast cancer: a real-world … Q Chen, D Ouyang, M Anwar, N Xie, S Wang, P Fan, L Qian, G Chen, ... Frontiers in Oncology 10, 811, 2020 | 41 | 2020 |
| Identification of lncRNAs via microarray analysis for predicting HER2-negative breast cancer response to neoadjuvant chemotherapy D Ouyang, J Su, P Huang, M Li, Q Li, P Zhao, Q Chen, Q Zou, X Feng, ... International journal of clinical and experimental pathology 11 (5), 2621, 2018 | 13 | 2018 |
| Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer Z Wang, L Qu, Q Chen, Y Zhou, H Duan, B Li, Y Weng, J Su, W Yi BMC cancer 23 (1), 128, 2023 | 11 | 2023 |
| A literature review of the promising future of TROP2: A potential drug therapy target Y Wen, D Ouyang, Q Zou, Q Chen, N Luo, H He, M Anwar, W Yi Annals of Translational Medicine 10 (24), 2022 | 11 | 2022 |
| Inhibition of autophagy with Chloroquine enhanced apoptosis induced by 5-aminolevulinic acid-photodynamic therapy in secondary hyperparathyroidism primary cells and organoids L Zeng, Q Zou, P Huang, L Xiong, Y Cheng, Q Chen, Y Li, H He, W Yi, ... Biomedicine & Pharmacotherapy 142, 111994, 2021 | 11 | 2021 |
| Prognosis comparison between nipple-sparing mastectomy and total mastectomy in breast cancer: a case-control study after propensity score matching M Fu, Q Chen, L Zeng, T Hong, Q Zou, Y Yuan, W Yi Annals of Surgical Oncology, 1-10, 2022 | 8 | 2022 |
| The efficacy of pyrotinib as a third-or higher-line treatment in HER2-positive metastatic breast cancer patients exposed to lapatinib compared to lapatinib-naive patients: a … DJ Ouyang, QT Chen, M Anwar, N Xie, QC Ouyang, PZ Fan, LY Qian, ... Frontiers in Pharmacology 12, 682568, 2021 | 8 | 2021 |
| METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+ HER2—breast cancer D Ouyang, T Hong, M Fu, Y Li, L Zeng, Q Chen, H He, Y Wen, Y Cheng, ... Breast Cancer Research 25 (1), 19, 2023 | 5 | 2023 |
| Chemotherapy significantly improves long-term survival of small lesion node negative metaplastic breast carcinoma in T1c population rather than T1a and T1b Q Chen, Q Zhou, H He, Y He, Y Yuan, Q Zou, W Yi Scientific Reports 12 (1), 871, 2022 | 5 | 2022 |
| Construction and validation of a risk prediction model for clinical axillary lymph node metastasis in T1–2 breast cancer N Luo, Y Wen, Q Zou, D Ouyang, Q Chen, L Zeng, H He, M Anwar, L Qu, ... Scientific Reports 12 (1), 687, 2022 | 5 | 2022 |
| Prognostic value of tumor mutation burden and the relationship between tumor mutation burden and immune infiltration in HER2+ breast cancer: a gene expression-based study Y Wen, D Ouyang, Q Chen, L Zeng, N Luo, H He, M Anwar, L Qu, Q Zou, ... Gland Surgery 11 (1), 100, 2022 | 5 | 2022 |
| Surgery of the primary tumor offers survival benefits of breast cancer with synchronous ipsilateral supraclavicular lymph node metastasis Q Chen, L Zeng, D Ouyang, P Zhao, Q Zou, L Pei, N Luo, W Yi World Journal of Surgery 44 (4), 1163-1172, 2020 | 5 | 2020 |
| Application of a Three-Dimensional Reconstruction System in Breast Cancer with Ipsilateral Supraclavicular Lymph Node Metastasis: A Case Series P Zhao, Q Zou, L Yuan, L Li, Q Chen, D Ouyang, W Yi Breast Care 14 (3), 176-179, 2019 | 4 | 2019 |
| Prognostic and tumor-immune infiltration cell signatures in tamoxifen-resistant breast cancers Z Cao, Z Jin, L Zeng, H He, Q Chen, Q Zou, D Ouyang, N Luo, Y Zhang, ... Gland Surgery 10 (9), 2766, 2021 | 2 | 2021 |
| RNA-Seq-based transcriptomics analysis during the photodynamic therapy of primary cells in secondary hyperparathyroidism Y Wen, L Zeng, Q Chen, Y Li, M Fu, Z Wang, H Liu, X Li, P Huang, W Wu, ... Photochemical & Photobiological Sciences 22 (4), 905-917, 2023 | 1 | 2023 |
| Corrigendum: effectiveness and safety of pyrotinib, and association of biomarker with progression-free survival in patients with HER2-positive metastatic breast cancer: a real … Q Chen, D Ouyang, M Anwar, N Xie, S Wang, P Fan, L Qian, G Chen, ... Frontiers in Oncology 11, 661128, 2021 | 1 | 2021 |
| Bioinformatics-based analysis of TCGA to identify the prognostic biomarkers in HR-positive/HER2-negative tamoxifen-treated breast cancer L Zeng, D Ouyang, Q Zou, Q Chen, N Luo, W Yi | 1 | 2019 |
| Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study J Peng, Y Hong, Q Chen, F Xu, D Zhang, J Yao, Q Zou, L Yuan, L Li, ... Frontiers in Endocrinology 15, 1347762, 2024 | | 2024 |
| Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer H Gao, D Ouyang, X Guan, J Xu, Q Chen, L Zeng, J Pang, Q Zou, K Qian, ... BMC cancer 24 (1), 50, 2024 | | 2024 |
